The following report is concerned with the study of magnesium metabolism in clinical and experimental hyperthyroidism. This first communication deals primarily with the ratio of diffusible magnesium to total serum magnesium in the hyperthyroid state.
METHOD
The total serum magnesium was determined by the method of Briggs (4) . The serum proteins were precipitated with trichloracetic acid. It was found that little, if any, magnesium was carried down with the protein flocculum. To 10 cc. of protein free filtrate were added 1 cc. of 20 per cent sodium acetate, 6 to 8 drops of 0.016 per cent bromcresol green, and 1 cc. of 4 per cent ammonium oxalate. The pH of the solution was adjusted to 5.0 by addition of ammonium hydroxide. The mixture was allowed to stand overnight, and the precipitated calcium oxalate then separated by centrifugation. To the decanted supernatant fluid and washings were added 1 cc. of 2 per cent potassium dihydrogen phosphate, Aided For the determination of diffusible magnesium, serum was ultrafiltered through a " 600 " Cellophane membrane under a pressure of 80 pounds nitrogen per square inch. The magnesium content of the ultrafiltrate was determined as described above, except that the protein precipitation with trichloracetic acid was omitted.
RESULTS
Total and ultrafiltrable magnesium determinations were made in normal individuals, in patients with neurocirculatory asthenia, various muscular dystrophies, and in patients with clinically well defined hyperthyroidism. In many of the latter group, determinations were made before and after the administration of Lugol's solution and after operation.
In Table I are presented the results obtained in 14 normal individuals. It was found that the percentage of the total serum magnesium which is non-diffusible varied in these individuals from 3.1 to 22.1 per cent, the largest number of the group falling between 10 and 19 per cent. The total serum magnesium varied between 2.12 and 2.76 mgm. per cent, with one exception of 4.30 mgm. per cent.
In Table II are included the data obtained in patients with neurocirculatory asthenia. The 597 The results obtained in this group are almost identical with those found in the normal individuals. The basal metabolic readings of the patients with neurocirculatory asthenia were all well within the normal limits. It is frequently difficult to distinguish clinically between this group and patients with definite hyperthyroidism. But, as we shall see in the subsequent tables, the behavior of the serum magnesium in normal individuals and in patients with neurocirculatory asthenia is entirely different from that in hyperthyroidism.
In Table II are also presented the results obtained in 7 patients with various myopathies. Five of these patients have myasthenia gravis, while 2 have progressive muscular dystrophy. Again, it will be seen that the results in these patients are identical with those of the normal group, with the exception of one patient with progressive muscular dystrophy who showed some elevation of the percentage of bound magnesium.
The results obtained in patients with Graves' disease were striking. For this study 31 instances of hyperthyroidism of varying intensity were investigated. In each instance the clinical diagnosis was confirmed by microscopic study of the thyroid gland removed at operation. In 13 of these 31 patients total and ultrafiltrate serum magnesium determinations were made before and after the administration of Lugol's solution, in 12 control and postoperative studies were conducted, and finally in 6 instances determinations were made before the administration of iodine, after the administration of Lugol's solution, and after operation. The postoperative specimens were collected 10 days after the operation just prior to discharge from the hospital.
In Table III In 13 patients, the total and bound magnesium in the blood was determined before and after the administration of Lugol's solution (Table IV) . There is no essential change in the total serum magnesium before and after adequate administration of iodine, but a considerable change occurred in the non-filtrable fraction. Thus, before the administration of Lugol's solution the bound mag- (Table IV) studies were conducted when they were first admitted to the hospital before receiving iodine, and again just before discharge from the hospital after subtotal thyroidectomy. The non-diffusible fraction before operation varied between 22.2 and 49.8 per cent, while postoperatively it varied between 0.0 and 20.5 per cent, a return to normal levels. This is again demonstrated in those 6 patients in whom determinations were made during the control period, after the administration of Lugol's solution, and after operation (Table IV) . After iodine administration, some drop occurred in the percentage of bound magnesium which dropped still further to normal levels after the operation. During the period of this study, we have had 2 patients with myxedema. In both patients the basal metabolic rate was minus 40 and in both instances there was no circulating bound magnesium, the direct opposite of the finding in pa-tients with hyperthyroidism. The total serum magnesium in the patients with myxedema was well within the normal range.
The mechanism which produces an increase in the percentage of bound magnesium in hyperthyroidism is obscure, and one may raise the question as to whether the blood colloids play some part in the binding mechanism. The amount of blood protein in our series, however, was no greater in patients with hyperthyroidism than in the normal individuals, so that we must postulate some change in the nature of the blood proteins to explain the increase in the binding mechanism. To investigate this phase we performed the following experiments: from 50 to 200 mgm. of thyroglobulin were injected intravenously in one dose into 5 dogs. The total and ultrafiltrable blood magnesium was determined at intervals of 15 minutes, 1, 5, and 24 hours. In each instance the increase in bound magnesium varied between 30 and 100 per cent over the control level (Table V) . This increase occurred 3. The patients with neurocirculatory asthenia and various types of muscular dystrophy showed no change in the percentage of bound magnesium as compared to the normals.
4. The patients with hyperthyroidism showed a marked increase in the non-diffusible fraction of the total blood magnesium. The percentage of bound magnesium in these patients varied between 21.5 and 61.6 per cent. 5. No relationship was noted between the basal metabolic rate and the percentage of bound magnesium.
6. Following lugolization there is a considerable decrease in the non-diffusible magnesium fraction with a further drop and return to normal levels after thyroidectomy.
7. In two patients with myxedema, there was no circulating bound magnesium.
8. Thyroglobulin injected intravenously into dogs produces a considerable transient increase in the non-diffusible magnesium fraction suggesting that this protein plays some part in the binding mechanism.
9. The determination of the percentage of bound magnesium may serve as a means for diagnosing obscure and borderline instances of hyperthyroidism.
